The latest price and purchasing methods of Ocrelizumab in 2025

Ocrelizumab is a monoclonal antibody drug used to treat relapsing and progressive multiple sclerosis (MS). It works by targeting and destroying B cells involved in the progression of multiple sclerosis, helping to reduce the number of relapses and slow the progression of disability. Ocrelizumabis indicated for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing forms of multiple sclerosis including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease in adults.

Multiple sclerosis is a disabling disease characterized by the immune system mistakenly attacking and damaging the myelin sheath in the brain, spinal cord, and optic nerves. Damage to this protective covering can lead to a variety of functional impairments in patients. The working mechanism of Orelizumab is to reduce the number of B cells in the body by binding to the CD20 protein on the surface of B cells, thereby reducing damage to nerves, thereby alleviating symptoms and preventing the progression of the disease. As a cytotoxic antibody, Orelizumab is effective against the immune response that triggers multiple sclerosis.

Regarding the price and purchase channels of orrelizumab, the original drug has been approved for marketing in China. However, due to its short time on the market, the current specific price and medical insurance reimbursement information have not yet been announced. In the international market, Orelizumab is relatively expensive, especially in the European market. Each box of 300 mg/10 mL medicine costs about more than 50,000 yuan. The specific price may vary due to exchange rate fluctuations.

It should be noted that there are currently no generic drugs of ocrelizumab on the market at home and abroad, so patients need to pay higher drug costs when choosing treatment. When patients purchase ocrelizumab, they can usually purchase it through hospital pharmacies or professional drug sales platforms, but they must consult a doctor before use to ensure that the drug is suitable for their health conditions.

Reference materials:https://www.ocrevus.com/